http://www.medscape.com/viewarticle/...r />
<br />
If you follow this link, it'll take you to an up to the minute article from medscape by Hal Burstein who is a researcher at Dana Farber. He lays out clearly how adriamycin is being thought of/used currently in her2 disease. It's a good, pretty readable article.
Best,
Jeff